Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ARX vs CRVL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ARX Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 5–4 Matrix Metrics)

ARX Overall Winner 6-Pillar Tally: ARX 5 – 1 CRVL Matrix Metrics: ARX 5 – 4 CRVL

As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over Corvel Corp (CRVL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas CRVL carries 42.6/100 (HOLD) at $87.34 (23.8x Forward P/E, 15.9% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ARX vs CRVL
ARX NYSE Head-to-Head Winner
Accelerant Holdings
Insurance Agents, Brokers & Service
$19.87
+0.1% 1D
Market Cap $4.3B
TTM Revenue $2.79B
Forward P/E 21.3x
Beta / 30D Vol -0.19β · 2% Vol
Unified Composite Score
46.9 / 100 HOLD
Tech 34.0 Fund 50.0 Flow 76.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.5% over 20 days), RSI 70
RSI-14: 69.8 · SMA20: $19.83 · SMA50: $19.80
CRVL NASDAQ
Corvel Corp
Insurance Agents, Brokers & Service
$87.34
+1.93% 1D
Market Cap $4.3B
TTM Revenue $1.01B
Forward P/E 23.8x
Beta / 30D Vol -0.17β · 33% Vol
Unified Composite Score
42.6 / 100 HOLD
Tech 42.0 Fund 40.0 Flow 50.0 Mom 25.9
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.9% over 20 days), RSI 66
RSI-14: 65.7 · SMA20: $83.74 · SMA50: $78.01

6-Pillar Scorecard Institutional Category Breakdown (ARX 5 – 1 CRVL)

Columns: Metric · ARX · CRVL
1. Valuation Multiples ARX
Forward P/E 21.3x 23.8x
Trailing P/E 27.6x 36.0x
PEG Ratio N/M N/M
EV / Revenue N/M 4.3x
2. Growth & Scale ARX
Revenue Growth (YoY) +6.1% +11.5%
Earnings Growth (YoY) +800.0% +24.1%
TTM Revenue (USD) $2.79B $1.01B
Market Cap $4.3B $4.3B
3. Profitability & Quality CRVL
Gross Margin 62.8% 25.5%
Operating Margin 3.7% 15.9%
Net Profit Margin 5.6% 12.0%
Return on Equity (ROE) 9.2% 30.6%
4. Balance Sheet & Cash Flow ARX
Cash Generation (TTM) $634M $195M EBITDA
Cash Flow Margin 22.7% 19.3% EBITDA Mgn
Net Cash / Leverage $5.13B Net Cash $8.54 Book/Sh · 30.6% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ARX
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 15.7% (3rd %ile) 187.6% (100th %ile)
Put/Call OI Skew 0.01x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat ARX
OpEx & R&D Intensity 59.1% of Rev ($1.65B) 9.6% of Rev ($97M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Insurance Brokers Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ARX (5) vs CRVL (4)
Institutional Metric ARX CRVL Criterion Row Edge
Market Capitalization
Scale
$4.3B $4.3B Larger Scale Tie
Trailing P/E Ratio
Valuation
27.6x 36.0x Lower Multiple ARX
Forward P/E Ratio
Valuation
21.3x 23.8x Lower Multiple ARX
Revenue Growth (YoY)
Growth
+6.1% +11.5% Higher Growth CRVL
Operating Margin (TTM)
Profitability
3.7% 15.9% Higher Margin CRVL
Net Profit Margin
Profitability
5.6% 12.0% Higher Margin CRVL
Return on Equity (ROE)
Capital Efficiency
9.2% 30.6% Higher ROE CRVL
52-Week Range Position
Momentum
100% ($9–$20) 95% ($45–$90) Stronger Trend ARX
Beta / 30D Volatility
Risk Regime
-0.19β · 2% Vol -0.17β · 33% Vol Lower Realized Risk ARX
Unified Institutional Score
Composite Signal
46.9 / 100 (HOLD) 42.6 / 100 (HOLD) Higher Composite ARX
Trailing 12M Revenue (USD)
Operating Scale
$2.79B $1.01B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
62.8% 25.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 4.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$634M ($5.13B Net Cash) $195M EBITDA ($8.54 Book/Sh · 30.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CRVL +8.99 pp
ARX: +0.61% · CRVL: +9.6%
3M Horizon CRVL +28.12 pp
ARX: +1.58% · CRVL: +29.7%
6M Horizon CRVL +22.87 pp
ARX: +24.89% · CRVL: +47.76%
1Y Horizon ARX +25.59 pp
ARX: +44.4% · CRVL: +18.81%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARX vs CRVL. Trailing 12-month operating profitability (ARX 3.7% vs CRVL 15.9%) and valuation multiples (ARX 21.3x vs CRVL 23.8x Forward P/E) are benchmarked directly in Pillar 4 below.

ARX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.79B
Gross Margin62.8%
Op. Margin3.7%
ROE / Fwd P/E9.2% · 21.3x
CRVL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.01B
Gross Margin25.5%
Op. Margin15.9%
ROE / Fwd P/E30.6% · 23.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ARX CONSOLIDATION
50d in phase · OBV NEUTRAL
Current IV 15.7%
IV Percentile 3rd %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ARX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CRVL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 187.6%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CRVL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ARX Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $4.3B market capitalization and 3.7% operating margin.
OpEx & R&D Reinvestment 59.1% of Rev ($1.65B)
90D Engineering Disclosures 0 Published
CRVL Moat Profile Scale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $4.3B market capitalization and 15.9% operating margin.
OpEx & R&D Reinvestment 9.6% of Rev ($97M)
90D Engineering Disclosures 0 Published

Investor FAQ ARX vs CRVL Key Questions & Quantitative Answers

As of Nov 16, 2026, Accelerant Holdings (ARX) is the stronger overall head-to-head candidate over Corvel Corp (CRVL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas CRVL carries 42.6/100 (HOLD) at $87.34 (23.8x Forward P/E, 15.9% operating margin). Technically, ARX sits in a Markup phase (RSI 69.8, CONSOLIDATION options structure) and CRVL sits in a Markup phase (RSI 65.7, UNCLASSIFIED options structure).

ARX leads the Growth & Scale pillar: ARX posts +6.1% YoY revenue growth and +800.0% YoY earnings growth on $2.79B TTM revenue (62.8% gross margin, 3.7% operating margin), compared with CRVL at +11.5% YoY revenue growth and +24.1% YoY earnings growth on $1.01B TTM revenue (25.5% gross margin, 15.9% operating margin). On trailing 12-month operating scale, ARX generates $2.79B in USD-normalized revenue versus $1.01B for CRVL. In operating R&D and SG&A reinvestment, ARX deploys 59.1% of Rev ($1.65B) (0 90-day corporate R&D disclosures) versus 9.6% of Rev ($97M) (0 disclosures) for CRVL.

ARX screens cheaper on headline valuation multiples. ARX trades at 21.3x Forward P/E, 27.6x Trailing P/E, N/M PEG, and N/M EV/Revenue (22.7% FCF margin), whereas CRVL trades at 23.8x Forward P/E, 36.0x Trailing P/E, N/M PEG, and 4.3x EV/Revenue (19.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARX (9.2% ROE) versus CRVL (30.6% ROE) capital efficiency.

In options market volatility and institutional positioning, ARX carries 15.7% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.19β · 2% Vol realized risk). By comparison, CRVL carries 187.6% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.17β · 33% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.